
NUE · NYSE
Consensus is Buy across 11 analysts, with a mean price target of $282.5. The supplied data do not provide a low or high target, so target clustering, dispersion, and the width of the range cannot be established. No named analyst is identified as the most or least bullish, and no rating or price-target revisions during the past week are supplied. The substantive disagreement therefore cannot be assigned to particular firms; the available evidence instead contrasts positive Zacks value and momentum commentary with Nucor’s lower fiscal 2025 net income despite higher revenue. The consensus is clearly positive, but analyst-level conviction and the reasons behind the target are not disclosed.